|
Sept. 07, 2020 |
|
|
Oct. 12, 2023 |
|
|
jRCT1052200052 |
Japanese HIS-bundle pacing for patient with indication of Cardiac Resynchronization Therapy Trial |
|
J-HIS-CRT |
|
Aug. 17, 2024 |
|
7 |
|
Seven patients were enrolled in the study and one withdrew consent. Age was 67.7 +-16.3 (mean +-standard deviation) in the CRT group and 66.3 +-8.8 in the His group, and the proportion of women was 33.3% in the CRT group and 0.0% in the His group, with no significant differences between the two groups. |
|
The enrolment period was 2.5 years until 31 March 2023, but the study was discontinued due to poor progress. |
|
Adverse events No adverse events occurred. |
|
No analysis was conducted due to the discontinuation of the study. |
|
No analysis was conducted due to the discontinuation of the study. |
|
Aug. 31, 2023 |
No |
|
No |
|
https://jrct.mhlw.go.jp/latest-detail/jRCT1052200052 |
Kusano Kengo |
||
National Cerebral and Cardiovascular Center Hospital |
||
6-1 Kishibe Shimmachi, Suita, Osaka, Japan |
||
+81-6-6170-1070 |
||
kusanokengo@ncvc.go.jp |
||
Yurugi Maki |
||
National Cerebral and Cardiovascular Center Hospital |
||
6-1 Kishibe Shimmachi, Suita, Osaka, Japan |
||
+81-6-6170-1070 |
||
yurugi.maki@ncvc.go.jp |
Complete |
Sept. 07, 2020 |
||
| Mar. 05, 2021 | ||
| 50 | ||
Interventional |
||
randomized controlled trial |
||
open(masking not used) |
||
active control |
||
parallel assignment |
||
treatment purpose |
||
1. Subject is 20 years of age or older at the time of consent acquisition |
||
1. Subject with a history of CRT implantation |
||
| 20age old over | ||
| No limit | ||
Both |
||
Heart Failure |
||
His-bundle pacing |
||
Heart Failure |
||
Responder rate 6 months after implantation |
||
1. Amount of change in cardiac function by myocardial scintigraphy at 6 months after implantation (left ventricular ejection fraction: LVEF, left ventricular end systolic volume: LVESV, etc.) |
||
| Intramural Research Fund (30-3-1)for Cardiovascular Diseases of National Cerebral and Cardiovascular Center Prospective Intervention Study Using the Existing Devices to Develop a New Therapeutic Guideline | |
| Not applicable |
| Osaka Metropolitan University Hospital Certified Review Board | |
| 6th floor of Abeno Medix,1-2-7 Asahicho,Abeno-ku,Osaka, Osaka | |
+81-6-6645-3456 |
|
| irb@med.osaka-cu.ac.jp | |
| Approval | |
Aug. 21, 2020 |
none |